AMYT.L
Amryt Pharma Holdings Ltd
Price:  
143.00 
GBP
Volume:  
90,627.00
United Kingdom | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AMYT.L WACC - Weighted Average Cost of Capital

The WACC of Amryt Pharma Holdings Ltd (AMYT.L) is 8.2%.

The Cost of Equity of Amryt Pharma Holdings Ltd (AMYT.L) is 8.65%.
The Cost of Debt of Amryt Pharma Holdings Ltd (AMYT.L) is 7.00%.

Range Selected
Cost of equity 7.20% - 10.10% 8.65%
Tax rate 0.10% - 0.40% 0.25%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.2% - 9.3% 8.2%
WACC

AMYT.L WACC calculation

Category Low High
Long-term bond rate 2.9% 3.4%
Equity market risk premium 5.3% 6.3%
Adjusted beta 0.8 0.97
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.20% 10.10%
Tax rate 0.10% 0.40%
Debt/Equity ratio 0.34 0.34
Cost of debt 7.00% 7.00%
After-tax WACC 7.2% 9.3%
Selected WACC 8.2%